Daily Oncology News

Eltrombopag: Noninferior to Intravenous Immunoglobulin in Immune Thrombocytopenia?

By

Jonathan Goodman, MPhil

Publish Date September 21, 2020

Eltrombopag may be an effective alternative to intravenous immunoglobulin for the perioperative treatment of immune thrombocytopenia.

HIFU Focal Ablation for PCa Offers Adequate Short-Term Cancer Control

By

Jody Charnow

Publish Date September 21, 2020

In a study, men who underwent high-intensity focused ultrasound partial gland ablation for prostate cancer had excellent preservation of potency and continence.

Multiple Myeloma: More Real-World Data Needed To Confirm Effectiveness of New Treatments

By

Jonathan Goodman, MPhil

Publish Date September 21, 2020

More data is needed to determine whether newer treatments are truly improving outcomes among patients with r/r multiple myeloma.

Mobility Tech: Focus on Ambulation, ADLs, and Personal Care in Hospitalized Patients With Cancer

By

Susan Moench, PhD, PA-C

Publish Date September 18, 2020

Incorporating this new position improved overall ambulation and personal hygiene among hospitalized patients on the oncology and BMT units.

Outcomes After Daratumumab Addition to Induction Therapy in Newly Diagnosed Multiple Myeloma

By

Lauren Dembeck, PhD

Publish Date September 18, 2020

Researchers assessed the effects of adding daratumumab to standard frontline induction therapy to treat MM in newly diagnosed, transplant-eligible patients.

COVID-19, SARS-CoV-2 Infection Phenotypes Vary With Different Tumor Subtypes

By

Rita Aghjayan

Publish Date September 18, 2020

Among patients with cancer, tumor subtypes may influence varying susceptibility to SARS-CoV-2 and COVID-19 disease phenotypes.

Radiotherapy Response Time Did Not Dictate Outcomes for Gastrointestinal Low-Grade B-Cell Lymphoma

By

Leah Lawrence

Publish Date September 18, 2020

Delayed evaluation could decrease unnecessary invasive tests.

Risk-Adapted Bendamustine and Rituximab: An Alternative for Older Individuals With CLL

By

Christina Bennett, MS

Publish Date September 18, 2020

Risk-adapted dosing of bendamustine and rituximab may be beneficial and tolerable for elderly patients with CLL, a retrospective study found.

Are Preoperative 3D Reconstructions of Pediatric Tumors Helpful?

By

Lauren Dembeck, PhD

Publish Date September 17, 2020

Researchers assessed the advantages and discrepancies of preoperative 3D reconstruction compared with 2D images and surgical findings in pediatric tumors.

Full-Time Nurse Position Facilitates Safe and Effective Chemotherapy Delivery

By

Susan Moench, PhD, PA-C

Publish Date September 17, 2020

Oncology nurse position was created to address barriers to safe, effective chemotherapy delivery both on and off the oncology inpatient units.

Implementing, Evaluating a Survivorship Program for Patients With Recurrent Breast Cancer

By

Susan Moench, PhD, PA-C

Publish Date September 17, 2020

The Healthy Outcomes for Positivity and Encouragement (HOPE) survivorship program offered nurse navigator-based coaching tailored to the unique needs of patients with recurrent breast cancer.

Best Practices for Replacing Peripherally Inserted Intravenous Catheters

By

Susan Moench, PhD, PA-C

Publish Date September 17, 2020

A literature review found that clinically indicated replacement of PIVs is better for older patients with cancer compared with timed replacement.

Oral or IV Dexamethasone Prophylaxis for Prevention of Paclitaxel-Related Hypersensitivity Reactions?

By

Susan Moench, PhD, PA-C

Publish Date September 17, 2020

Literature review prompts a call for randomized, controlled trials comparing oral and IV dexamethasone prophylaxis in the setting of paclitaxel administration.

Immunotherapy Improves Survival Despite Brain Metastases

By

Jody A. Charnow

Publish Date September 17, 2020

Immunotherapy improved median overall survival by 7.5 months regardless of what other treatments patients received.

Molecular Profiling Can Assess Risk for Myeloproliferative Neoplasms With Splanchnic Vein Thrombosis

By

Jessica Nye, PhD

Publish Date September 16, 2020

Researchers sought to markers that could identify high risk for splanchnic vein thrombosis among patients with MPNs.

Skin Cancer Clinical Trials

Clinical Trial: The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)

Clinical trial focusing on herditary nonpolyposis colon cancer. The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)

Clinical Trial: Spectral Diagnosis of Cutaneous Malignancy

Clinical trial focusing on spectral diagnosis. Spectral Diagnosis of Cutaneous Malignancy

Clinical Trial: Electronic Brachytherapy for the Treatment of NMSC

Clinical trial focusing on electronic brachytherapy. Electronic Brachytherapy for the Treatment of NMSC

Clinical Trial: Use of the Epidermal Micrografts for Wound Healing After Mohs or Excisional Surgery for Skin Cancer

Clinical trial focusing on epidermal micrografts. Use of the Epidermal Micrografts for Wound Healing After Mohs or Excisional Surgery for Skin Cancer

Clinical Trial: Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project

Clinical trial focusing on Mohs surgery project. Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project